These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 2468921

  • 21. Regional differences of beta 1- and beta 2-adrenoceptor-mediated functions in feline heart. A beta 2-adrenoceptor-mediated positive inotropic effect possibly unrelated to cyclic AMP.
    Lemoine H, Kaumann AJ.
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):56-69. PubMed ID: 1685558
    [Abstract] [Full Text] [Related]

  • 22. Human cardiac beta-adrenoceptors: both beta 1- and beta 2-adrenoceptors are functionally coupled to the adenylate cyclase in right atrium.
    Brodde OE, O'Hara N, Zerkowski HR, Rohm N.
    J Cardiovasc Pharmacol; 1984 Jul; 6(6):1184-91. PubMed ID: 6084778
    [Abstract] [Full Text] [Related]

  • 23. Impaired contractile response to beta adrenoceptor stimulation in diabetic rat hearts: alterations in beta adrenoceptors-G protein-adenylate cyclase system and phospholamban phosphorylation.
    Gando S, Hattori Y, Akaishi Y, Nishihira J, Kanno M.
    J Pharmacol Exp Ther; 1997 Jul; 282(1):475-84. PubMed ID: 9223590
    [Abstract] [Full Text] [Related]

  • 24. In kitten ventricular myocardium, the inotropic potency of an agonist is determined by both its intrinsic activity for the adenylyl cyclase and its affinity for the beta-adrenoceptors.
    Kaumann AJ.
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Aug; 317(1):13-8. PubMed ID: 6116196
    [No Abstract] [Full Text] [Related]

  • 25. In vivo regulation of human cardiac beta-adrenoceptors by a partial agonist as compared with a full antagonist: selective differences in coupling to adenylate cyclase.
    Arnold IR, Mistry R, Barnett DB.
    J Cardiovasc Pharmacol; 1993 Sep; 22(3):481-7. PubMed ID: 7504142
    [Abstract] [Full Text] [Related]

  • 26. [Importance of beta 2-adrenergic receptors in heart failure].
    Brodde OE, Daul A, Michel MC, Zerkowski HR.
    Z Kardiol; 1992 Sep; 81 Suppl 4():71-8. PubMed ID: 1363262
    [Abstract] [Full Text] [Related]

  • 27. [Pharmacological studies on alterations in myocardial beta-adrenoceptors and their intracellular signal transduction in experimental diabetic rats].
    Gando S.
    Hokkaido Igaku Zasshi; 1994 Sep; 69(5):1140-53. PubMed ID: 7868054
    [Abstract] [Full Text] [Related]

  • 28. Enantiomers of dobutamine increase the force of contraction via beta adrenoceptors, but antagonize competitively the positive inotropic effect mediated by alpha-1 adrenoceptors in the rabbit ventricular myocardium.
    Ishihata A, Kushida H, Endoh M.
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1080-7. PubMed ID: 2843626
    [Abstract] [Full Text] [Related]

  • 29. Human heart beta-adrenoceptors: beta1-adrenoceptor diversification through 'affinity states' and polymorphism.
    Molenaar P, Chen L, Semmler AB, Parsonage WA, Kaumann AJ.
    Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1020-8. PubMed ID: 17714089
    [Abstract] [Full Text] [Related]

  • 30. Beta 2-adrenoceptor-mediated positive inotropic effect of adrenaline in human ventricular myocardium. Quantitative discrepancies with binding and adenylate cyclase stimulation.
    Kaumann AJ, Lemoine H.
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Apr; 335(4):403-11. PubMed ID: 2885760
    [Abstract] [Full Text] [Related]

  • 31. [Role of adrenergic beta receptor partial agonists in left ventricular failure of ischemic origin. Value of xamoterol (ICI 118,587, Corwin)].
    Rousseau MF, Cheron P, Nannan M, Vincent MF, Lavenne F, Pouleur H.
    Ann Med Interne (Paris); 1985 Apr; 136(3):247-50. PubMed ID: 2862823
    [Abstract] [Full Text] [Related]

  • 32. Mode of action of (-)-pindolol on feline and human myocardium.
    Kaumann AJ, Lobnig BM.
    Br J Pharmacol; 1986 Sep; 89(1):207-18. PubMed ID: 2879589
    [Abstract] [Full Text] [Related]

  • 33. Does myocardial adenyl cyclase represent the cardiac beta-receptor?
    Strosberg AM, Waterbury LD.
    Proc West Pharmacol Soc; 1976 Sep; 19():466-9. PubMed ID: 11505
    [No Abstract] [Full Text] [Related]

  • 34. A comparison of the effects of adrenaline and noradrenaline on human heart: the role of beta 1- and beta 2-adrenoceptors in the stimulation of adenylate cyclase and contractile force.
    Kaumann AJ, Hall JA, Murray KJ, Wells FC, Brown MJ.
    Eur Heart J; 1989 Jun; 10 Suppl B():29-37. PubMed ID: 2572419
    [Abstract] [Full Text] [Related]

  • 35. Effects of xamoterol on the reversible cycling of cardiac beta-adrenoceptors.
    Limas CJ, Limas C.
    J Cardiovasc Pharmacol; 1990 Dec; 16(6):945-51. PubMed ID: 1704988
    [Abstract] [Full Text] [Related]

  • 36. Bucindolol exerts agonistic activity on the propranolol-insensitive state of beta1-adrenoceptors in human myocardium.
    Bundkirchen A, Brixius K, Bölck B, Schwinger RH.
    J Pharmacol Exp Ther; 2002 Mar; 300(3):794-801. PubMed ID: 11861783
    [Abstract] [Full Text] [Related]

  • 37. The human heart beta-adrenergic receptors. II. Coupling of beta 2-adrenergic receptors with the adenylate cyclase system.
    Waelbroeck M, Taton G, Delhaye M, Chatelain P, Camus JC, Pochet R, Leclerc JL, De Smet JM, Robberecht P, Christophe J.
    Mol Pharmacol; 1983 Sep; 24(2):174-82. PubMed ID: 6136901
    [Abstract] [Full Text] [Related]

  • 38. The functional importance of beta 1 and beta 2 adrenoceptors in the human heart.
    Brodde OE.
    Am J Cardiol; 1988 Aug 11; 62(5):24C-29C. PubMed ID: 2900601
    [Abstract] [Full Text] [Related]

  • 39. The role of cardiac beta1- and beta2-adrenoceptor stimulation in heart failure.
    Khamssi M, Brodde OE.
    J Cardiovasc Pharmacol; 1990 Aug 11; 16 Suppl 5():S133-7. PubMed ID: 11527117
    [Abstract] [Full Text] [Related]

  • 40. The in vitro pharmacology of xamoterol (ICI 118,587).
    Malta E, Mian MA, Raper C.
    Br J Pharmacol; 1985 May 11; 85(1):179-87. PubMed ID: 2862938
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.